Post

👏Raffaella presenting at #EANO2026 today. The ARGOS post hoc analysis of EORTC-1709-BTG/CCTG CE.8 (MIRAGE) explored the relationship between radiotherapy quality assurance (RTQA), uninvolved-brain dose, survival, and treatment-related toxicity in patients with glioblastoma.

1 repost1 like

No replies yet.